This report contains market size and forecasts of D-Dimer in China, including the following market information:
China D-Dimer Market Revenue, 2016-2021, 2022-2027, ($ millions)
China top five D-Dimer companies in 2020 (%)
The global D-Dimer market size is expected to growth from US$ 1788 million in 2020 to US$ 2240.8 million by 2027; it is expected to grow at a CAGR of 3.2% during 2021-2027.
The China D-Dimer market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the D-Dimer Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China D-Dimer Market,

By Type

, 2016-2021, 2022-2027 ($ Millions)
China D-Dimer Market Segment Percentages,

By Type

, 2020 (%)
Deep Venous Thrombosis
Pulmonary Embolism
Venous Thromboembolism

China D-Dimer Market,

By Application

, 2016-2021, 2022-2027 ($ Millions)
China D-Dimer Market Segment Percentages,

By Application

, 2020 (%)
Monoclonal Antibodies
Chromogenic Substrates
DNA Probes
Immunoassays
Biochips/Microarrays
IT and Other Technologies

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies D-Dimer revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies D-Dimer revenues share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Becton
Bio/Data
Beckman Coulter
Dickinson
Corgenix
F. Nanogen
Hoffmann-La Roche
Siemens Healthcare
Trinity Biotech
Thermo & Fischer Scientific